Leishmania donovani BPK282A1 complete genome, chromosome 16.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799603.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
eukaryotic translation initiation factor 1A, putative
mitochondrial ornithine carrier protein-like protein
mitochondrial ornithine transporter 1-like protein
protein tyrosine phosphatase-like protein
protein tyrosine phosphatase-likie protein
proteasome 26S non-ATPase subunit 9, putative
aspartate carbamoyltransferase, putative
orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative
apurinic/apyrimidinic endonuclease-redox protein
flagellar calcium-binding protein, putative
tyrosyl or methionyl-tRNA synthetase-like protein
DNA-directed rna polymerase I largest subunit, putative
trafficking protein particle complex subunit-like protein
endoplasmic reticulum oxidoreductin, putative
DNA polymerase I alpha catalytic subunit, putative
U1 small nuclear ribonucleoprotein, putative
eukaryotic translation initiation factor 4 gamma, putative